Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by jopatcloon Aug 07, 2024 9:59am
77 Views
Post# 36167345

Excellent (and brief) overview of Ventripoint Diagnostics Lt

Excellent (and brief) overview of Ventripoint Diagnostics LtInteresting post remenber on Ventripoint 
Excellent (and brief) overview of Ventripoint Diagnostics Ltd.'s approved hashtagechocardiography hashtagAI product that provides particular utility for complex cases, pediatrics and RV.

Several world leading cardiology hospitals have recently adopted the product, including Duke University (2nd system), Deutsches Herzzentrum der Charit, Evelina Children's, and Children’s Heart Centre Vienna.

hashtagcardiology hashtagechofirst hashtagmedtech

<< Previous
Bullboard Posts
Next >>